Gland Pharma Q2 Results | Revenue from operations increased 2.4% to ₹1,405.8 crore. Shares of Gland Pharma Ltd ended at ₹1,602.35, down by ₹42.50, or 2.58%, on the BSE.
Gland Pharma Q2 Results | Revenue from operations increased 2.4% to ₹1,405.8 crore. Shares of Gland Pharma Ltd ended at ₹1,602.35, down by ₹42.50, or 2.58%, on the BSE.